PTC Therapeutics
PTCT
PTCT
350 hedge funds and large institutions have $7.04B invested in PTC Therapeutics in 2025 Q4 according to their latest regulatory filings, with 99 funds opening new positions, 126 increasing their positions, 96 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
19% more funds holding
Funds holding: 293 → 350 (+57)
11.39% more ownership
Funds ownership: 104.08% → 115.47% (+11%)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Holders
350
Holding in Top 10
7
Calls
$22.4M
Puts
$17.4M
Top Buyers
| 1 | +$410M | |
| 2 | +$78.3M | |
| 3 | +$77.9M | |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$64.8M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$58.8M |
Top Sellers
| 1 | -$76.4M | |
| 2 | -$75.1M | |
| 3 | -$41.9M | |
| 4 |
AC
Armistice Capital
New York
|
-$34.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$31.2M |
